University of Crete (UOC)
Μελέτη της αποτελεσματικότητας των βραχείας και μακράς διάρκειας δράσεως βρογχοδιασταλτικών φαρμάκων σε μηχανικά αεριζόμενους ασθενείς με χρόνια αποφρακτική πνευμονοπάθεια και παραγόντων που την επηρεάζουν
Abstract
dc:descriptionThe delivery of bronchodilators -particularly beta2-agonists- by metered dose inhaler (MDI) in mechanically ventilated. COPD patients have received considerable interest in recent years. This is because the use of an MDI has several advantages over the nebulizer in terms of ease of administration reduced cost and safety. Provided that the technique of administration is proper MDIs seem to be as effective as nebulizers despite a significantly lower dose of bronchodilator delivered by the MDI. While several studies have examined the effect of various ventilatory parameters (like tidal volume increase application of an end-inspiratory pause different flow/time profile different flow rate) on bronchodilator efficacy the effect of spontaneous respiratory efforts on beta2-agomst induced bronchodilation has never been studied in humans. Furthermore, while the duration of the bronchodilator response to short as well as long-acting beta2-agonists has been established in spontaneously breathing COPD patients it has not been studied in mechanically ventilated patients with COPD exacerbation. Hence, the following questions were studied: - duration of the bronchodilator effect induced by the short-acting beta2-agonist salbutamol, - influence of respiratory efforts on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients. - duration of the bronchodilator effect induced by the long-acting beta2-agonist salmeterol in mechanically ventilated COPD patients. The resulting main conclusions were the following: In mechanically ventilated patients with COPD exacerbation administration of the short-acting beta2-agonist salbutamol as well as the long-acting beta2-agonist salmeterol by MDI and a spacer device causes significant reduction of respiratory resistance indices (Rmin and Rmax), In mechanically ventilated patients with COPD exacerbation administration of 600 μg of the short-acting, beta2-agonist salbutamol caused a significant bronchodilator response which was evident at 15 minutes after administration and remained relatively constant for approximately 3 hours although significant inter-patient variability was noticed. - The magnitude of bronchodilation induced by salbutamol delivered by an MDI and a spacer device in mechanically ventilated COPD patients is not affected by the presence or absence of active respiratory efforts. - In mechanically ventilated patients with COPD exacerbation administration of 100 μg of the long-acting beta2-agonist salmeterol caused a significant bronchodilator response which was evident at 30 minutes after administration and remained relatively constant for approximately 8 hours. Duration of bronchodilator effect varied significantly among patients precluding definite conclusions regarding an optimum dosing schedule which should be titrated according to objective indices of bronchodilation.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Malliotakis, Polychronis
- Μαλλιωτάκης, Πολυχρόνης
Subjects
dc:subject × 16- Μηχανικός αερισμός
- Χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
- Βρογχοδιασταλτικά
- Σαλβουταμόλη
- Σαλμετερόλη
- Μηχανικές ιδιότητες αναπνευστικού συστήματος
- Mechanical ventilation
- Chronic obstructive pulmonary disease (COPD)
- Bronchodilators
- Salbutamol
- Salmeterol
- Respiratory system mechanics
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24440